Chr. Hansen Holding A/S (CHYHY)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Chr. Hansen Holding A/S (CHYHY) trades at $19.59 with AI Score 48/100 (Grade C). Chr. Market cap: $10.31B, Sector: Basic materials.
Price live · AI analysis from Jun 14, 2026Analyst Coverage for CHYHY: CHYHY does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CHYHY against Basic Materials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
CHYHY: the 1 perspectives are evenly split.
How is this calculated? →Chr. Hansen Holding A/S (CHYHY) Materials & Commodity Exposure
Chr. Hansen Holding A/S is a prominent bioscience enterprise that develops natural ingredient solutions for various industries, emphasizing sustainability and health benefits, with a strong market presence across multiple global regions.
What Is the Investment Thesis for CHYHY?
Chr. Hansen Holding A/S operates in a robust market characterized by increasing demand for natural ingredients across various sectors. With a market capitalization of $10.31B and a P/E ratio of 42.75, the company demonstrates strong profitability, evidenced by a profit margin of 17.0% and a gross margin of 54.2%. Growth catalysts include the expanding global demand for health and nutrition products, with the Health & Nutrition segment expected to drive significant revenue growth. The strategic collaboration with UPL Ltd. is anticipated to enhance its market position in sustainable agriculture, potentially increasing revenue streams from this sector. The company's commitment to innovation and sustainability is a key value driver, aligning with global trends towards healthier and environmentally friendly products. However, investors should monitor potential risks, including market competition and regulatory challenges in the bioscience industry.
Based on FMP financials and quantitative analysis
CHYHY Key Highlights
- Market capitalization of $10.31B reflects strong investor confidence and market position.
- P/E ratio of 42.75 indicates a premium valuation compared to industry peers, suggesting expectations of future growth.
- Profit margin of 17.0% highlights effective cost management and operational efficiency.
- Gross margin of 54.2% exceeds industry averages, showcasing strong pricing power and product differentiation.
- Beta of 0.31 indicates lower volatility compared to the market, suggesting a stable investment profile.
Who Are CHYHY's Competitors?
CHYHY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| SVJTY PJSC Severstal | $21.90 | +0.00% | $18.35B | — |
| HMTLY Hitachi Metals, Ltd. | $265.75 | +0.00% | $11.36B | 46 |
| ACHHY Aluminum Corporation of China Limited | $10.12 | -5.24% | $11.22B | 44 |
| AWCMY Alumina Limited | $3.69 | -2.89% | $10.71B | 43 |
| BOLIF Boliden AB (publ) | $34.65 | +0.00% | $9.48B | 42 |
| HGRAF HydroGraph Clean Power Inc. | $3.43 | -3.11% | $1.20B | 69 |
| LWLG Lightwave Logic, Inc. | $7.46 | +1.29% | $1.15B | 69 |
| COOSF Carbios SAS | $6.50 | -9.09% | $109.66M | 69 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CHYHY's Key Strengths?
- Established brand with a long history and strong market recognition.
- Diverse product portfolio catering to multiple industries.
- Robust R&D capabilities driving innovation and product development.
- Strong financial performance with high profit margins.
What Are CHYHY's Weaknesses?
- Limited dividend payout may deter income-focused investors.
- High P/E ratio could indicate overvaluation compared to peers.
- Dependence on specific sectors, such as dairy, may pose risks.
What Could Drive CHYHY Stock Higher?
- Launch of new probiotic products targeting the dietary supplement market.
- Strategic collaboration with UPL Ltd. to develop sustainable agricultural solutions.
- Continuous investment in R&D to innovate natural ingredient solutions.
- Expansion into emerging markets with increasing demand for health-oriented products.
- Strengthening of partnerships within the food and nutrition sectors.
What Are the Key Risks for CHYHY?
- Regulatory changes impacting the bioscience industry.
- Intense competition from other specialty chemical companies.
- Fluctuations in currency exchange rates affecting profitability.
- Economic downturns leading to reduced consumer spending in key markets.
What Are the Growth Opportunities for CHYHY?
- Expansion in Health & Nutrition: The global dietary supplements market is projected to reach $278 billion by 2024, driven by increasing health awareness. Chr. Hansen's Health & Nutrition segment is poised to capture this growth through innovative product offerings, particularly in probiotics and functional foods, enhancing its market share.
- Sustainable Agriculture Solutions: With the global market for sustainable agriculture projected to grow significantly, Chr. Hansen's collaboration with UPL Ltd. to develop microbial-based bio-solutions positions the company to capitalize on this trend, potentially generating new revenue streams and enhancing its product portfolio.
- Dairy Sector Innovations: The dairy industry continues to evolve, with a growing demand for natural and health-oriented products. Chr. Hansen's expertise in food cultures and enzymes allows it to introduce innovative solutions that meet consumer preferences, thereby strengthening its leadership position in this segment.
- Emerging Markets Growth: As economies in the Asia Pacific and Latin America continue to develop, there is an increasing demand for high-quality food and nutritional products. Chr. Hansen's global reach and established presence in these regions position it to benefit from this expanding market.
- Technological Advancements: Investment in R&D to develop new natural ingredients and formulations can drive growth. By leveraging cutting-edge technology, Chr. Hansen can enhance its product offerings and maintain a competitive edge in the specialty chemicals industry.
What Opportunities Does CHYHY Have?
- Growing demand for natural ingredients in health and nutrition sectors.
- Expansion into emerging markets with increasing consumer demand.
- Partnerships for sustainable agriculture solutions present new revenue streams.
What Threats Does CHYHY Face?
- Intense competition from other specialty chemical companies.
- Regulatory challenges in the bioscience industry.
- Market volatility and economic downturns affecting consumer spending.
What Are CHYHY's Competitive Advantages?
- Strong brand reputation built over 180 years in the bioscience industry.
- Extensive R&D capabilities leading to continuous product innovation.
- Established global presence with a diverse customer base across multiple industries.
- Strategic partnerships that enhance product offerings and market access.
- Focus on sustainability, aligning with consumer trends towards health and environmental responsibility.
What Does CHYHY Do?
Founded in 1843, Chr. Hansen Holding A/S has established itself as a distinguished bioscience company headquartered in Hørsholm, Denmark. The company specializes in crafting natural ingredient solutions that cater to a diverse range of industries, including food, nutritional, pharmaceutical, and agricultural sectors. Its operations are divided into two main segments: Food Cultures & Enzymes and Health & Nutrition. The Food Cultures & Enzymes segment focuses on providing cultures, enzymes, and probiotic products that enhance the taste, aroma, texture, shelf life, and nutritional value of consumer food items, particularly in the dairy sector. The Health & Nutrition segment develops and distributes products for dietary supplements, over-the-counter pharmaceuticals, infant formula, animal feed, and plant protection. A key strategic partnership with UPL Ltd. is aimed at creating microbial-based bio-solutions for sustainable agriculture, demonstrating the company's commitment to innovation and environmental sustainability. Over the years, Chr. Hansen has evolved to meet the changing demands of its global customer base, which spans Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific. The company's focus on natural ingredients positions it favorably in a market increasingly driven by consumer preference for health-conscious and sustainable products.
What Products and Services Does CHYHY Offer?
- Develop natural ingredient solutions for food, nutritional, pharmaceutical, and agricultural industries.
- Produce cultures, enzymes, and probiotic products that enhance food quality and health benefits.
- Create products for dietary supplements, over-the-counter pharmaceuticals, and infant formulas.
- Collaborate with industry partners to innovate sustainable agricultural solutions.
- Focus on research and development to drive product innovation and market expansion.
- Serve a diverse global customer base across multiple industries and regions.
How Does CHYHY Make Money?
- Generate revenue through the sale of natural ingredients and solutions to various industries.
- Leverage R&D to develop innovative products that meet changing consumer demands.
- Establish strategic partnerships to enhance product offerings and market reach.
- Focus on sustainability to align with market trends and consumer preferences.
- Utilize a global distribution network to serve customers in multiple regions.
What Industry Does CHYHY Operate In?
The specialty chemicals industry, particularly in the bioscience sector, is experiencing significant growth driven by increasing consumer demand for natural and sustainable products. The global market for natural ingredients is projected to expand, with a growing emphasis on health and nutrition. Chr. Hansen Holding A/S is well-positioned within this landscape, competing with companies such as PJSC Severstal (SVJTY), Hitachi Metals, Ltd. (HMTLY), Aluminum Corporation of China Limited (ACHHY), Alumina Limited (AWCMY), and Boliden AB (publ) (BOLIF). The company's focus on innovation and sustainability aligns with broader industry trends, making it a key player in the ongoing shift towards natural solutions in various sectors.
Who Are CHYHY's Key Customers?
- Food manufacturers seeking natural ingredient solutions for product enhancement.
- Nutritional supplement companies looking for high-quality probiotics and functional ingredients.
- Pharmaceutical companies requiring natural components for over-the-counter products.
- Agricultural businesses interested in sustainable solutions for crop protection and animal feed.
- Infant formula producers needing safe and effective nutritional ingredients.
F-Score 6/9Financial Health
Chr. Hansen Holding A/S's Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 5.03 places it in the safe zone, indicating low near-term bankruptcy risk.
CHYHY Valuation & Market Position
With a $10.31B market cap, Chr. Hansen Holding A/S sits in the large-cap segment of the market. Relative to its peer group, CHYHY's quantitative score of 48/100 is roughly in line with the peer average of 44/100.
ROE 22%Key Financial Metrics
Return on equity for Chr. Hansen Holding A/S stands at 21.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 6.6%, showing how much profit it generates from its asset base. CHYHY trades at a trailing price-to-earnings ratio of 42.75, above the Basic Materials sector average of ~22x. Its free cash flow yield is 2.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.44 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 2.3%, the inverse of the P/E and a quick read on earnings relative to price.
Company Profile
Chr. Hansen Holding A/S operates in the Chemicals - Specialty industry within the Basic Materials sector. It is headquartered in Horsholm, DK. The company is led by CEO Mauricio Graber. CHYHY has traded publicly since 2014.
CHYHY Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's long-term growth prospects, indicating that those closest to the business see value.
- Community sentiment has shifted positively, with discussions highlighting the company's innovative product pipeline in natural food ingredients.
- Market perception is buoyed by Chr. Hansen's strong sustainability initiatives, aligning with consumer trends towards healthier and environmentally friendly products.
- Analysts have noted the company's resilience during economic fluctuations, reinforcing the belief that it can weather market volatility effectively.
Bear Case
- There are concerns about rising raw material costs impacting profit margins, which could dampen overall financial performance.
- Recent community discussions reflect skepticism about the company's ability to maintain growth rates in a competitive landscape.
- Some investors are wary of potential regulatory challenges in the food industry, which could affect product offerings and market access.
- Market sentiment has shown caution regarding global supply chain disruptions, raising fears about Chr. Hansen's operational efficiency in the near term.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
CHYHY Latest News
No recent news available for CHYHY.
CHYHY Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CHYHY.
Price Targets
Wall Street price target analysis for CHYHY.
CHYHY MoonshotScore
What does this score mean?
The MoonshotScore rates CHYHY's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Mauricio Graber
CEO
Mauricio Graber has extensive experience in the bioscience and food industries, having held various leadership roles over his career. He has a strong educational background in business and management, enabling him to steer Chr. Hansen towards innovation and growth. His leadership style emphasizes sustainability and operational excellence, aligning with the company's mission to provide natural solutions.
Track Record: Under Mauricio Graber's leadership, Chr. Hansen has strengthened its market position through strategic collaborations and a focus on R&D. His commitment to sustainability has driven initiatives that align the company's product offerings with consumer demand for health-conscious solutions.
Chr. Hansen Holding A/S ADR Information Unsponsored
An American Depositary Receipt (ADR) represents shares in a foreign company traded on U.S. exchanges. For Chr. Hansen Holding A/S, CHYHY is a Level I ADR, allowing U.S. investors to gain exposure to the company's shares without dealing with foreign stock exchanges directly.
- Home Market Ticker: Hørsholm, DK
- ADR Level: 1
- ADR Ratio: 1:1
- Home Market Ticker: CHYH
CHYHY OTC Market Information
The OTC Other tier includes stocks that do not meet the requirements for higher tiers like the NYSE or NASDAQ. These stocks may have lower liquidity and less stringent reporting standards, which can affect investor access and information availability.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Lower liquidity may result in higher volatility and price discrepancies.
- Less stringent reporting standards can lead to information asymmetry.
- Potential for wider bid-ask spreads, increasing transaction costs.
- Verify the company's financial health through available reports.
- Assess the competitive landscape and market position.
- Understand the regulatory environment affecting the bioscience sector.
- Examine the company's growth strategy and R&D pipeline.
- Monitor currency risks associated with foreign investments.
- Established history and reputation in the bioscience industry.
- Transparent communication of financial performance and strategic goals.
- Active engagement in sustainability initiatives and partnerships.
Chr. Hansen Holding A/S Basic Materials Stock: Key Questions Answered
What does Chr. Hansen Holding A/S do?
Chr. Hansen Holding A/S specializes in developing natural ingredient solutions for various industries, including food, nutritional, pharmaceutical, and agricultural sectors. The company operates through two main segments: Food Cultures & Enzymes, which enhances food quality, and Health & Nutrition, which focuses on dietary supplements and pharmaceuticals.
What do analysts say about CHYHY stock?
Analysts generally recognize Chr. Hansen Holding A/S as a leader in the bioscience sector, noting its strong financial metrics, including a profit margin of 17.0% and a gross margin of 54.2%. The company's strategic focus on sustainability and innovation is viewed positively, although its high P/E ratio of 42.75 raises questions about valuation compared to peers.
What are the main risks for CHYHY?
Key risks for Chr. Hansen Holding A/S include intense competition within the specialty chemicals industry, which could pressure margins and market share. Additionally, regulatory changes could impact operations, while currency fluctuations may affect profitability for U.S. investors. Economic downturns could also lead to reduced consumer spending on premium products.
What are the key factors to evaluate for CHYHY?
Chr. Hansen Holding A/S (CHYHY) holds an AI score of 48/100 (low). Not financial advice.
How frequently does CHYHY data refresh on this page?
CHYHY prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven CHYHY's recent stock price performance?
Chr. Hansen Holding A/S (CHYHY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established brand with a long history and strong market recognition. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CHYHY overvalued or undervalued right now?
Valuing Chr. Hansen Holding A/S (CHYHY) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying CHYHY?
Before investing in Chr. Hansen Holding A/S (CHYHY), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Data is based on the latest available information as of June 2026.